Skip left navigation

Clinical Pharmacy Clinical Guidelines & Policies - UnitedHealthcare Community Plan of Arizona

UnitedHealthcare Community Plan’s Clinical Pharmacy Program Guidelines are updated on an ongoing basis by our Pharmacy and Therapeutics Committee. Our changes reflect recent developments in pharmaceutical health care so we’re aligned with national treatment standards.

These guidelines apply to the following plans:

Arizona AHCCCS Complete Care / Medicaid
Arizona Developmentally Disabled-Children's Rehabilitative Services (DD-CRS) Program
Arizona Developmentally Disabled (DD) Program
Arizona Long Term Care

Filter through lots of information with little effort by clicking this button

Actemra - Clinical Pharmacy Program Guidelines - UnitedHealthcare Community Plan of Arizona
Last Modified 05.24.2019
Acthar Gel - Clinical Pharmacy Program Guidelines - UnitedHealthcare Community Plan of Arizona
Last Modified 07.19.2019
Actimmune (interferon gamma-1b) - Clinical Pharmacy Program Guidelines - UnitedHealthcare Community Plan of Arizona
Last Modified 08.30.2019

Actimmune (interferon gamma-1b)
ADHD Products - Clinical Pharmacy Program Guidelines - UnitedHealthcare Community Plan of Arizona
Last Modified 08.15.2019

Adderall XR (amphetamine/dextroamphetamine salts extended release) capsule Adderall (amphetamine/ dextroamphetamine salts) tablet Aptensio XR (methylphenidate) capsule 24hr Concerta (methylphenidate) ER tablet Daytrana (methylphenidate) patch Focalin (dexmethylphenidate) tablet Focalin XR (dexmethylphenidate extended release) capsule Kapvay (clonidine) extended release tablet Methylin (methylphenidate) solution Quillichew ER (methylphenidate ex tended release) chewable tablet Quillivant XR (methylphenidate) suspension Ritalin LA 10mg (methylphenidate ER) capsule Vyvanse (lisdexamfetamine) capsule Vyvanse (lisdexamfetamine) chewable tablet Amphetamine -dextroamphetamine tablets Atomoxetine capsule Clonidine t ablet Dextroamphetamine extended release capsule Dextroamphetamine tablet Guanfacine extended release tablet Guanfacine tablet Methylphenidate controlled release/ 24 hr tablet Methylphenidate extended release capsule (generic Metadate CD) Methylphenidate extended release tablet (generic Metadate ER) Methylphenidate tablet Adzenys XR (amphetamine) ER ODT Cotempla XR (methylphenidate) ODT Desoxyn (methamphetamine) tablet Dexedrine (dextroamphetamine) spansule/ tablet Dyanavel XR (amphetamine) suspension Confidential and Proprietary, © 2018 UnitedHealthcare Services Inc. 2 Evekeo (amphetamine) tablet Intuniv (guanfacine) tablet Metadat e CD (methylphenidate extended release) capsule Metadate (methylphenidate) ER tablet Methylin (methylphenidate) chew Mydayis (mixed amphetamine salts) ER capsule Procentra (dextroamphetamine) solution Ritalin (methylphenidate) tablet Ritalin LA 20, 30,40,60 mg (methylphenidate ER) capsule Strattera (atomoxetine) capsule Zenzedi (dextroamphetamine) tablet Amphetamine -dextroamphetamine XR capsules (generic Adderall XR) Dexmethylphendiate 24hr capsule (generic Focalin XR) Dexmethylphenidate tablet (generic Focalin) Dextroamphetamine solution (generic Procentra) Dextroamphetamine tablet (generic Zenzedi) Methamphetamine tablet (generic Desoxyn) Methylphenidate chewable tablet Methylphenidate ER tablet (generic Concerta) Methylphenidate ER capsule (generic Ritalin LA) Methylphenidate solution (generic Methylin
Afinitor (everolimus) - Clinical Pharmacy Program Guidelines - UnitedHealthcare Community Plan of Arizona
Last Modified 07.19.2019
Afrezza - Clinical Pharmacy Program Guidelines - UnitedHealthcare Community Plan of Arizona
Last Modified 08.30.2019

Afrezza (insulin human)
Aldurazyme - Clinical Pharmacy Program Guidelines - UnitedHealthcare Community Plan of Arizona
Last Modified 11.30.2018
Alecensa - Clinical Pharmacy Program Guidelines - UnitedHealthcare Community Plan of Arizona
Last Modified 11.30.2018
Alfa Interferons - Clinical Pharmacy Program Guidelines - UnitedHealthcare Community Plan of Arizona
Last Modified 11.01.2018
Alinia - Clinical Pharmacy Program Guidelines - UnitedHealthcare Community Plan of Arizona
Last Modified 01.30.2019
Alunbrig (brigatinib) - Clinical Pharmacy Program Guidelines - UnitedHealthcare Community Plan of Arizona
Last Modified 08.31.2018
Alzheimer's Agents - Clinical Pharmacy Program Guidelines - UnitedHealthcare Community Plan of Arizona
Last Modified 11.30.2018
Ampyra (dalfampridine) - Clinical Pharmacy Program Guidelines - UnitedHealthcare Community Plan of Arizona
Last Modified 07.19.2019
Anthelmintics - Clinical Pharmacy Program Guidelines - UnitedHealthcare Community Plan of Arizona
Last Modified 11.01.2018
Anticonvulsants - Clinical Pharmacy Program Guidelines - UnitedHealthcare Community Plan of Arizona
Last Modified 07.17.2019
Antidepressants - Clinical Pharmacy Program Guidelines - UnitedHealthcare Community Plan of Arizona
Last Modified 07.19.2019
Antiemetics - Clinical Pharmacy Program Guidelines - UnitedHealthcare Community Plan of Arizona
Last Modified 02.15.2019
Antiglaucoma Agents - Clinical Pharmacy Program Guidelines - UnitedHealthcare Community Plan of Arizona
Last Modified 02.15.2019
Antipsoriatic Agents - Clinical Pharmacy Program Guidelines - UnitedHealthcare Community Plan of Arizona
Last Modified 12.28.2018
Antipsychotics - Clinical Pharmacy Program Guidelines - UnitedHealthcare Community Plan of Arizona
Last Modified 07.17.2019
Apokyn - Clinical Pharmacy Program Guidelines - UnitedHealthcare Community Plan of Arizona
Last Modified 01.18.2019
Aquadeks - Clinical Pharmacy Program Guidelines - UnitedHealthcare Community Plan of Arizona
Last Modified 04.24.2019
Aralast NP - Clinical Pharmacy Program Guidelines - UnitedHealthcare Community Plan of Arizona
Last Modified 02.18.2019
Arcalyst - Clinical Pharmacy Program Guidelines - UnitedHealthcare Community Plan of Arizona
Last Modified 07.17.2019
Arikayce - Clinical Pharmacy Program Guidelines - UnitedHealthcare Community Plan of Arizona
Last Modified 05.24.2019
Austedo - Clinical Pharmacy Program Guidelines - UnitedHealthcare Community Plan of Arizona
Last Modified 04.24.2019
Azole Antifungals - Clinical Pharmacy Program Guidelines - UnitedHealthcare Community Plan of Arizona
Last Modified 07.17.2019
Azole Antifungals - Clinical Pharmacy Program Guidelines - UnitedHealthcare Community Plan of Arizona
Last Modified 08.30.2019

Sporanox (itraconazole) capsules, Sporanox (itraconazole) oral solution, Onmel (itraconazole) tablets, Vfend (voriconazole) tablets, Vfend (voriconazole) powder for oral suspension, Noxafil (posaconazole) tablets, Noxafil (posaconazole) oral suspension, Cresemba (isavuconazonium) capsules, Tolsura (itraconazole) capsule
Balversa - Clinical Pharmacy Program Guidelines - UnitedHealthcare Community Plan of Arizona
Last Modified 08.30.2019

Balversa (erdafitinib)
Belbuca / Butrans - Clinical Pharmacy Program Guidelines - UnitedHealthcare Community Plan of Arizona
Last Modified 07.17.2019
Benlysta - Clinical Pharmacy Program Guidelines - UnitedHealthcare Community Plan of Arizona
Last Modified 11.30.2018
Benznidazole - Clinical Pharmacy Program Guidelines - UnitedHealthcare Community Plan of Arizona
Last Modified 04.24.2019
Berinert - Clinical Pharmacy Program Guidelines - UnitedHealthcare Community Plan of Arizona
Last Modified 09.28.2018
Biltricide - Clinical Pharmacy Program Guidelines - UnitedHealthcare Community Plan of Arizona
Last Modified 12.28.2018
Bonjesta and Diclegis - Clinical Pharmacy Program Guidelines - UnitedHealthcare Community Plan of Arizona
Last Modified 10.01.2018
Bosulif - Clinical Pharmacy Program Guidelines - UnitedHealthcare Community Plan of Arizona
Last Modified 04.24.2019
Braftovi - Clinical Pharmacy Program Guidelines - UnitedHealthcare Community Plan of Arizona
Last Modified 03.31.2019
Breast Cancer - Clinical Pharmacy Program Guidelines - UnitedHealthcare Community Plan of Arizona
Last Modified 02.18.2019
Brilinta / Effient - Clinical Pharmacy Program Guidelines - UnitedHealthcare Community Plan of Arizona
Last Modified 12.28.2018
Buphenyl - Clinical Pharmacy Program Guidelines - UnitedHealthcare Community Plan of Arizona
Last Modified 11.30.2018
Cablivi - Clinical Pharmacy Program Guidelines - UnitedHealthcare Community Plan of Arizona
Last Modified 07.17.2019
Cabometyx - Clinical Pharmacy Program Guidelines - UnitedHealthcare Community Plan of Arizona
Last Modified 05.24.2019
Calquence - Clinical Pharmacy Program Guidelines - UnitedHealthcare Community Plan of Arizona
Last Modified 03.31.2019
Caprelsa - Clinical Pharmacy Program Guidelines - UnitedHealthcare Community Plan of Arizona
Last Modified 09.28.2018
Carbaglu - Clinical Pharmacy Program Guidelines - UnitedHealthcare Community Plan of Arizona
Last Modified 09.28.2018
Cayston - Clinical Pharmacy Program Guidelines - UnitedHealthcare Community Plan of Arizona
Last Modified 04.24.2019
Celebrex - Clinical Pharmacy Program Guidelines - UnitedHealthcare Community Plan of Arizona
Last Modified 05.24.2019
Cesamet, Marinol, Syndros - Clinical Pharmacy Program Guidelines - UnitedHealthcare Community Plan of Arizona
Last Modified 12.28.2018
CGRP - Clinical Pharmacy Program Guidelines - UnitedHealthcare Community Plan of Arizona
Last Modified 03.31.2019
Cholbam - Clinical Pharmacy Program Guidelines - UnitedHealthcare Community Plan of Arizona
Last Modified 11.30.2018
Cialis for BPH - Clinical Pharmacy Program Guidelines - UnitedHealthcare Community Plan of Arizona
Last Modified 04.24.2019
Cimzia - Clinical Pharmacy Program Guidelines - UnitedHealthcare Community Plan of Arizona
Last Modified 07.19.2019
Cinryze - Clinical Pharmacy Program Guidelines - UnitedHealthcare Community Plan of Arizona
Last Modified 09.28.2018
Ciprodex - Clinical Pharmacy Program Guidelines - UnitedHealthcare Community Plan of Arizona
Last Modified 05.24.2019
CMV and Herpes Virus Agents - Clinical Pharmacy Program Guidelines - UnitedHealthcare Community Plan of Arizona
Last Modified 02.18.2019
Colcrys - Clinical Pharmacy Program Guidelines - UnitedHealthcare Community Plan of Arizona
Last Modified 02.18.2019
Colony Stimulating Factors - Clinical Pharmacy Program Guidelines - UnitedHealthcare Community Plan of Arizona
Last Modified 07.19.2019
Combination Basal Insulin / GLP-1 Receptor Agonist - Clinical Pharmacy Program Guidelines - UnitedHealthcare Community Plan of Arizona
Last Modified 06.29.2018
Combination DPP4-SGLT2 - Clinical Pharmacy Program Guidelines - UnitedHealthcare Community Plan of Arizona
Last Modified 02.18.2019
Cometriq (cabocantinib) - Clinical Pharmacy Program Guidelines - UnitedHealthcare Community Plan of Arizona
Last Modified 08.30.2019

Cometriq (cabozantinib)
Complement Inhibitors (Soliris® & Ultomiris™) -Clinical Pharmacy Program Guidelines - UnitedHealthcare Community Plan of Arizona
Last Modified 05.24.2019
Compound Bulk Powders - Clinical Pharmacy Program Guidelines - UnitedHealthcare Community Plan of Arizona
Last Modified 09.28.2018
Concentrated Insulins - Clinical Pharmacy Program Guidelines - UnitedHealthcare Community Plan of Arizona
Last Modified 06.25.2018
Copiktra - Clinical Pharmacy Program Guidelines - UnitedHealthcare Community Plan of Arizona
Last Modified 01.30.2019
Copper Chelating Agents - Clinical Pharmacy Program Guidelines - UnitedHealthcare Community Plan of Arizona
Last Modified 08.30.2019

Copper Chelating Agents [Syprine (trientine), Cuprimine (penicillamine), Depen Titratable (penicillamine)]
Corlanor - Clinical Pharmacy Program Guidelines - UnitedHealthcare Community Plan of Arizona
Last Modified 03.31.2019
Cosentyx - Clinical Pharmacy Program Guidelines - UnitedHealthcare Community Plan of Arizona
Last Modified 03.31.2019
Cotellic - Clinical Pharmacy Program Guidelines - UnitedHealthcare Community Plan of Arizona
Last Modified 01.30.2019
Crestor - Clinical Pharmacy Program Guidelines - UnitedHealthcare Community Plan of Arizona
Last Modified 04.24.2019
Cystaran (cysteamine) - Clinical Pharmacy Program Guidelines - UnitedHealthcare Community Plan of Arizona
Last Modified 08.30.2019

Cystaran (cysteamine) ophthalmic solution
Daliresp - Clinical Pharmacy Program Guidelines - UnitedHealthcare Community Plan of Arizona
Last Modified 12.28.2018
Daraprim - Clinical Pharmacy Program Guidelines - UnitedHealthcare Community Plan of Arizona
Last Modified 07.12.2019
Daurismo.docx, Daurismo - Clinical Pharmacy Program Guidelines - UnitedHealthcare Community Plan of Arizona
Last Modified 03.31.2019
DDAVP - Clinical Pharmacy Program Guidelines - UnitedHealthcare Community Plan of Arizona
Last Modified 02.18.2019
Declomycin - Clinical Pharmacy Program Guidelines - UnitedHealthcare Community Plan of Arizona
Last Modified 02.18.2019
Dificid - Clinical Pharmacy Program Guidelines - UnitedHealthcare Community Plan of Arizona
Last Modified 07.19.2019
Dofetilide - Clinical Pharmacy Program Guidelines - UnitedHealthcare Community Plan of Arizona
Last Modified 02.19.2019
Doptelet - Clinical Pharmacy Program Guidelines - UnitedHealthcare Community Plan of Arizona
Last Modified 07.19.2019
DPP-4 Inhibitors - Clinical Pharmacy Program Guidelines - UnitedHealthcare Community Plan of Arizona
Last Modified 11.30.2018
Dry Eye Disease - Clinical Pharmacy Program Guidelines - UnitedHealthcare Community Plan of Arizona
Last Modified 07.19.2019
Duexis and Vimovo - Clinical Pharmacy Program Guidelines - UnitedHealthcare Community Plan of Arizona
Last Modified 07.16.2019
Duopa - Clinical Pharmacy Program Guidelines - UnitedHealthcare Community Plan of Arizona
Last Modified 11.30.2018
Dupixent - Clinical Pharmacy Program Guidelines - UnitedHealthcare Community Plan of Arizona
Last Modified 07.17.2019
Egrifta - Clinical Pharmacy Program Guidelines - UnitedHealthcare Community Plan of Arizona
Last Modified 04.24.2019
Elidel / Protopic - Clinical Pharmacy Program Guidelines - UnitedHealthcare Community Plan of Arizona
Last Modified 11.01.2018
Elmiron - Clinical Pharmacy Program Guidelines - UnitedHealthcare Community Plan of Arizona
Last Modified 12.28.2018
Emflaza - Clinical Pharmacy Program Guidelines - UnitedHealthcare Community Plan of Arizona
Last Modified 07.17.2019
Emsam - Clinical Pharmacy Program Guidelines - UnitedHealthcare Community Plan of Arizona
Last Modified 02.19.2019
Enbrel - Clinical Pharmacy Program Guidelines - UnitedHealthcare Community Plan of Arizona
Last Modified 05.24.2019
Endari - Clinical Pharmacy Program Guidelines - UnitedHealthcare Community Plan of Arizona
Last Modified 01.30.2019
Entocort - Clinical Pharmacy Program Guidelines - UnitedHealthcare Community Plan of Arizona
Last Modified 12.28.2018
Entresto - Clinical Pharmacy Program Guidelines - UnitedHealthcare Community Plan of Arizona
Last Modified 04.24.2019
Epaned - Clinical Pharmacy Program Guidelines - UnitedHealthcare Community Plan of Arizona
Last Modified 11.30.2018
Eplerenone - Clinical Pharmacy Program Guidelines - UnitedHealthcare Community Plan of Arizona
Last Modified 02.19.2019
Erivedge - Clinical Pharmacy Program Guidelines - UnitedHealthcare Community Plan of Arizona
Last Modified 11.30.2018
Erleada (apalutmide) - Clinical Pharmacy Program Guidelines - UnitedHealthcare Community Plan of Arizona
Last Modified 07.19.2019
Erythropoietic Agents - Clinical Pharmacy Program Guidelines - UnitedHealthcare Community Plan of Arizona
Last Modified 07.19.2019
Erythropoietic Agents - Clinical Pharmacy Program Guidelines - UnitedHealthcare Community Plan of Arizona
Last Modified 07.17.2019
Estrogens - Clinical Pharmacy Program Guidelines - UnitedHealthcare Community Plan of Arizona
Last Modified 02.19.2019
Etoposide - Clinical Pharmacy Program Guidelines - UnitedHealthcare Community Plan of Arizona
Last Modified 02.19.2019
Eucrisa - Clinical Pharmacy Program Guidelines - UnitedHealthcare Community Plan of Arizona
Last Modified 09.28.2018
Evzio - Clinical Pharmacy Program Guidelines - UnitedHealthcare Community Plan of Arizona
Last Modified 06.25.2018
Exondys 51 - Clinical Pharmacy Program Guidelines - UnitedHealthcare Community Plan of Arizona
Last Modified 05.24.2019
Farydak - Clinical Pharmacy Program Guidelines - UnitedHealthcare Community Plan of Arizona
Last Modified 05.24.2019
Fenofibrate - Clinical Pharmacy Program Guidelines - UnitedHealthcare Community Plan of Arizona
Last Modified 01.30.2019
Fentanyl IR - Clinical Pharmacy Program Guidelines - UnitedHealthcare Community Plan of Arizona
Last Modified 06.29.2018
Firazyr - Clinical Pharmacy Program Guidelines - UnitedHealthcare Community Plan of Arizona
Last Modified 09.28.2018
Firdapse - Clinical Pharmacy Program Guidelines - UnitedHealthcare Community Plan of Arizona
Last Modified 04.24.2019
Flexeril - Clinical Pharmacy Program Guidelines - UnitedHealthcare Community Plan of Arizona
Last Modified 02.19.2019
Flucytosine - Clinical Pharmacy Program Guidelines - UnitedHealthcare Community Plan of Arizona
Last Modified 02.19.2019
Forteo - Clinical Pharmacy Program Guidelines - UnitedHealthcare Community Plan of Arizona
Last Modified 07.19.2019
Galafold - Clinical Pharmacy Program Guidelines - UnitedHealthcare Community Plan of Arizona
Last Modified 01.09.2019
Gattex - Clinical Pharmacy Program Guidelines - UnitedHealthcare Community Plan of Arizona
Last Modified 11.30.2018
Gaucher’s Disease Agents - Clinical Pharmacy Program Guidelines - UnitedHealthcare Community Plan of Arizona
Last Modified 07.19.2019
Gilotrif (afatinib) - Clinical Pharmacy Program Guidelines - UnitedHealthcare Community Plan of Arizona
Last Modified 08.30.2019

Gilotrif (afatinib)
Gleevec - Clinical Pharmacy Program Guidelines - UnitedHealthcare Community Plan of Arizona
Last Modified 11.30.2018
GLP-1 Agonists - Clinical Pharmacy Program Guidelines - UnitedHealthcare Community Plan of Arizona
Last Modified 08.30.2019

Preferred Products: Victoza (liraglutide), Byetta (exenatide), Bydureon (exenatide extended-release) Non-Preferred Products: Bydureon BCise (exenatide extended-release),Trulicity (dulaglutide), Adlyxin (lixisenatide), Ozempic (semaglutide)
Glumetza-Fortamet-Glucophage XR - Clinical Pharmacy Program Guidelines - UnitedHealthcare Community Plan of Arizona
Last Modified 02.19.2019
Glumetza-Fortamet-Glucophage XR - Clinical Pharmacy Program Guidelines - UnitedHealthcare Community Plan of Arizona
Last Modified 07.17.2019
Gonadotropin-Releasing Hormone Agonists - Clinical Pharmacy Program Guidelines - UnitedHealthcare Community Plan of Arizona
Last Modified 02.19.2019
Gralise, Horizant - Clinical Pharmacy Program Guidelines - UnitedHealthcare Community Plan of Arizona
Last Modified 02.19.2019
Growth Hormone / Growth Stimulating Agents - Clinical Pharmacy Program Guidelines - UnitedHealthcare Community Plan of Arizona
Last Modified 06.25.2018
Haegarda - Clinical Pharmacy Program Guidelines - UnitedHealthcare Community Plan of Arizona
Last Modified 09.28.2018
HCG - Clinical Pharmacy Program Guidelines - UnitedHealthcare Community Plan of Arizona
Last Modified 07.19.2019
Hemangeol - Clinical Pharmacy Program Guidelines - UnitedHealthcare Community Plan of Arizona
Last Modified 12.28.2018
Hemlibra - Clinical Pharmacy Program Guidelines - UnitedHealthcare Community Plan of Arizona
Last Modified 03.31.2019
Hemophilia Products - Clinical Pharmacy Program Guidelines - UnitedHealthcare Community Plan of Arizona
Last Modified 02.25.2019
Hepatitis B - Clinical Pharmacy Program Guidelines - UnitedHealthcare Community Plan of Arizona
Last Modified 02.19.2019
Hepatitis C Agents - Clinical Pharmacy Program Guidelines - UnitedHealthcare Community Plan of Arizona
Last Modified 02.25.2019
Hetlioz - Clinical Pharmacy Program Guidelines - UnitedHealthcare Community Plan of Arizona
Last Modified 07.19.2019
Humira - Clinical Pharmacy Program Guidelines - UnitedHealthcare Community Plan of Arizona
Last Modified 05.24.2019
Hycamtin - Clinical Pharmacy Program Guidelines - UnitedHealthcare Community Plan of Arizona
Last Modified 01.30.2019
Ibrance - Clinical Pharmacy Program Guidelines - UnitedHealthcare Community Plan of Arizona
Last Modified 07.19.2019
Iclusig - Clinical Pharmacy Program Guidelines - UnitedHealthcare Community Plan of Arizona
Last Modified 01.30.2019
ICS.LABA Combination Products - Clinical Pharmacy Program Guidelines - UnitedHealthcare Community Plan of Arizona
Last Modified 07.31.2018
Idhifa - Clinical Pharmacy Program Guidelines - UnitedHealthcare Community Plan of Arizona
Last Modified 12.28.2018
Idiopathic Pulmonary Fibrosis - Clinical Pharmacy Program Guidelines - UnitedHealthcare Community Plan of Arizona
Last Modified 11.30.2018
Ilaris - Clinical Pharmacy Program Guidelines - UnitedHealthcare Community Plan of Arizona
Last Modified 03.31.2019
Imbruvica - Clinical Pharmacy Program Guidelines - UnitedHealthcare Community Plan of Arizona
Last Modified 11.30.2018
Immune Globulin - Clinical Pharmacy Program Guidelines - UnitedHealthcare Community Plan of Arizona
Last Modified 07.19.2019
Impavido - Clinical Pharmacy Program Guidelines - UnitedHealthcare Community Plan of Arizona
Last Modified 06.25.2018
Inbrija - Clinical Pharmacy Program Guidelines - UnitedHealthcare Community Plan of Arizona
Last Modified 07.19.2019
Inderal LA - Clinical Pharmacy Program Guidelines - UnitedHealthcare Community Plan of Arizona
Last Modified 06.25.2018
Ingrezza - Clinical Pharmacy Program Guidelines - UnitedHealthcare Community Plan of Arizona
Last Modified 12.28.2018
Inhaled Corticosteroids - Clinical Pharmacy Program Guidelines - UnitedHealthcare Community Plan of Arizona
Last Modified 05.01.2019
Inlyta - Clinical Pharmacy Program Guidelines - UnitedHealthcare Community Plan of Arizona
Last Modified 09.28.2018
Insulin Pen Needles and Syringes - Clinical Pharmacy Program Guidelines - UnitedHealthcare Community Plan of Arizona
Last Modified 02.19.2019
Iressa - Clinical Pharmacy Program Guidelines - UnitedHealthcare Community Plan of Arizona
Last Modified 11.30.2018
Iron Chelators - Clinical Pharmacy Program Guidelines - UnitedHealthcare Community Plan of Arizona
Last Modified 11.30.2018
Irritable Bowel Syndrome (IBS) Constipation - Clinical Pharmacy Program Guidelines - UnitedHealthcare Community Plan of Arizona
Last Modified 08.30.2019

Amitiza (lubiprostone), Linzess (linaclotide), Movantik (naloxegol), Trulance (plecanatide), Symproic (naldemedine), Motegrity (prucalopride)
Irritable Bowel Syndrome - Clinical Pharmacy Program Guidelines - UnitedHealthcare Community Plan of Arizona
Last Modified 05.24.2019
Isotretinoin - Clinical Pharmacy Program Guidelines - UnitedHealthcare Community Plan of Arizona
Last Modified 07.17.2019
Jakafi (ruxolitinib) - Clinical Pharmacy Program Guidelines - UnitedHealthcare Community Plan of Arizona
Last Modified 05.24.2019
Juxtapid - Clinical Pharmacy Program Guidelines - UnitedHealthcare Community Plan of Arizona
Last Modified 11.30.2018
Jynarque - Clinical Pharmacy Program Guidelines - UnitedHealthcare Community Plan of Arizona
Last Modified 01.09.2019
Kalydeco - Clinical Pharmacy Program Guidelines - UnitedHealthcare Community Plan of Arizona
Last Modified 11.01.2018
Keveyis - Clinical Pharmacy Program Guidelines - UnitedHealthcare Community Plan of Arizona
Last Modified 04.24.2019
Kevzara - Clinical Pharmacy Program Guidelines - UnitedHealthcare Community Plan of Arizona
Last Modified 05.24.2019
Kineret - Clinical Pharmacy Program Guidelines - UnitedHealthcare Community Plan of Arizona
Last Modified 05.24.2019
Kisqali - Clinical Pharmacy Program Guidelines - UnitedHealthcare Community Plan of Arizona
Last Modified 11.30.2018
Kisqali Femera Co-Pack - Clinical Pharmacy Program Guidelines - UnitedHealthcare Community Plan of Arizona
Last Modified 12.21.2018
Korlym - Clinical Pharmacy Program Guidelines - UnitedHealthcare Community Plan of Arizona
Last Modified 05.24.2019
Kuvan - Clinical Pharmacy Program Guidelines - UnitedHealthcare Community Plan of Arizona
Last Modified 09.28.2018
Kynamro - Clinical Pharmacy Program Guidelines - UnitedHealthcare Community Plan of Arizona
Last Modified 11.30.2018
LAMA / LABA - Clinical Pharmacy Program Guidelines - UnitedHealthcare Community Plan of Arizona
Last Modified 02.19.2019
Lenvima - Clinical Pharmacy Program Guidelines - UnitedHealthcare Community Plan of Arizona
Last Modified 01.30.2019
Leucovorin - Clinical Pharmacy Program Guidelines - UnitedHealthcare Community Plan of Arizona
Last Modified 02.19.2019
Lidocaine - Clinical Pharmacy Program Guidelines - UnitedHealthcare Community Plan of Arizona
Last Modified 05.24.2019
Lidocaine Patch - Clinical Pharmacy Program Guidelines - UnitedHealthcare Community Plan of Arizona
Last Modified 06.25.2018
Lokelma-Veltassa - Clinical Pharmacy Program Guidelines - UnitedHealthcare Community Plan of Arizona
Last Modified 04.10.2019
Long-Acting Opioid Products - Clinical Pharmacy Program Guidelines - UnitedHealthcare Community Plan of Arizona
Last Modified 08.15.2019

Morphine sulfate controlled-release tablets, fentanyl transdermal*, Embeda (morphine sulfate and naltrexone), Xtampza ER (oxycodone extended-release), tramadol extended release tablets (non-biphasic release tablets) Avinza (morphine sulfate extended-release capsules), Exalgo (hydromorphone extended-release), Kadian (morphine sulfate sustained-release capsules), MS Contin [brand name], Opana ERcrush resistant (oxymorphone extended-release), fentanyl transdermal 37.5mcg/hr, 62.5mcg/hr, and 87.5mcg/hr, Zohydro ER (hydrocodone extended-release), oxymorphone ER (generic non-crush resistant), methadone, Arymo (morphine sulfate extended-release tablet) ER, Morphabond ER (morphine sulfate extended-release), Troxyca ER (oxycodone and naltrexone extended-release), Vantrela ER (hydrocodone bitartrate extendedrelease), Hysingla ER (hydrocodone extended release), OxyContin (oxycodone controlled release), Nucynta ER (tapentadol extended release), tramadol extended release capsules, tramadol extended release biphasic release tablets
Lonhala and Yupelri - Clinical Pharmacy Program Guidelines - UnitedHealthcare Community Plan of Arizona
Last Modified 02.25.2019
Lonsurf - Clinical Pharmacy Program Guidelines - UnitedHealthcare Community Plan of Arizona
Last Modified 07.17.2019
Lorbrena.docx, Lorbrena - Clinical Pharmacy Program Guidelines - UnitedHealthcare Community Plan of Arizona
Last Modified 03.31.2019
Lucemyra - Clinical Pharmacy Program Guidelines - UnitedHealthcare Community Plan of Arizona
Last Modified 01.30.2019
Lynparza (olaparib) - Clinical Pharmacy Program Guidelines - UnitedHealthcare Community Plan of Arizona
Last Modified 05.24.2019
Lyrica - Clinical Pharmacy Program Guidelines - UnitedHealthcare Community Plan of Arizona
Last Modified 12.28.2018
Lysteda - Clinical Pharmacy Program Guidelines - UnitedHealthcare Community Plan of Arizona
Last Modified 12.28.2018
Makena - Clinical Pharmacy Program Guidelines - UnitedHealthcare Community Plan of Arizona
Last Modified 05.24.2019
Mavenclad - Clinical Pharmacy Program Guidelines - UnitedHealthcare Community Plan of Arizona
Last Modified 07.19.2019
Mayzent - Clinical Pharmacy Program Guidelines - UnitedHealthcare Community Plan of Arizona
Last Modified 07.19.2019
Mekinist - Clinical Pharmacy Program Guidelines - UnitedHealthcare Community Plan of Arizona
Last Modified 05.24.2019
Mektovi - Clinical Pharmacy Program Guidelines - UnitedHealthcare Community Plan of Arizona
Last Modified 03.31.2019
Mepron - Clinical Pharmacy Program Guidelines - UnitedHealthcare Community Plan of Arizona
Last Modified 07.17.2019
Migranal - Clinical Pharmacy Program Guidelines - UnitedHealthcare Community Plan of Arizona
Last Modified 05.24.2019
Mirvaso - Clinical Pharmacy Program Guidelines - UnitedHealthcare Community Plan of Arizona
Last Modified 11.01.2018
Mozobil - Clinical Pharmacy Program Guidelines - UnitedHealthcare Community Plan of Arizona
Last Modified 01.30.2019
Mulpleta - Clinical Pharmacy Program Guidelines - UnitedHealthcare Community Plan of Arizona
Last Modified 01.09.2019
Multaq - Clinical Pharmacy Program Guidelines - UnitedHealthcare Community Plan of Arizona
Last Modified 08.30.2019

Multaq (dronedarone)
Multiple Sclerosis (MS) Agents - Clinical Pharmacy Program Guidelines - UnitedHealthcare Community Plan of Arizona
Last Modified 01.30.2019
Myalept - Clinical Pharmacy Program Guidelines - UnitedHealthcare Community Plan of Arizona
Last Modified 07.19.2019
Mytesi - Clinical Pharmacy Program Guidelines - UnitedHealthcare Community Plan of Arizona
Last Modified 04.24.2019
Namzaric - Clinical Pharmacy Program Guidelines - UnitedHealthcare Community Plan of Arizona
Last Modified 08.30.2019

Namzaric (memantine extended-release/donepezil)
Natpara - Clinical Pharmacy Program Guidelines - UnitedHealthcare Community Plan of Arizona
Last Modified 11.30.2018
Nerlynx - Clinical Pharmacy Program Guidelines - UnitedHealthcare Community Plan of Arizona
Last Modified 11.30.2018
Nexavar - Clinical Pharmacy Program Guidelines - UnitedHealthcare Community Plan of Arizona
Last Modified 09.28.2018
Ninlaro - Clinical Pharmacy Program Guidelines - UnitedHealthcare Community Plan of Arizona
Last Modified 05.24.2019
Nityr - Clinical Pharmacy Program Guidelines - UnitedHealthcare Community Plan of Arizona
Last Modified 07.17.2019
Noctiva and Nocdurna - Clinical Pharmacy Program Guidelines - UnitedHealthcare Community Plan of Arizona
Last Modified 12.28.2018
Non-Preferred Drugs - Clinical Pharmacy Program Guidelines - UnitedHealthcare Community Plan of Arizona
Last Modified 08.30.2019

Non-Preferred Drugs
Non-Solid Dosage Forms - Clinical Pharmacy Program Guidelines - UnitedHealthcare Community Plan of Arizona
Last Modified 05.24.2019
Northera - Clinical Pharmacy Program Guidelines - UnitedHealthcare Community Plan of Arizona
Last Modified 06.29.2018
Nuedexta - Clinical Pharmacy Program Guidelines - UnitedHealthcare Community Plan of Arizona
Last Modified 12.28.2018
Nuplazid - Clinical Pharmacy Program Guidelines - UnitedHealthcare Community Plan of Arizona
Last Modified 11.02.2018
Ocaliva (obeticholic acid) - Clinical Pharmacy Program Guidelines - UnitedHealthcare Community Plan of Arizona
Last Modified 08.30.2019

Ocaliva (obeticholic acid)
Odomzo - Clinical Pharmacy Program Guidelines - UnitedHealthcare Community Plan of Arizona
Last Modified 11.30.2018
Olumiant - Clinical Pharmacy Program Guidelines - UnitedHealthcare Community Plan of Arizona
Last Modified 05.24.2019
Optivar - Clinical Pharmacy Program Guidelines - UnitedHealthcare Community Plan of Arizona
Last Modified 01.30.2019
Orencia - Clinical Pharmacy Program Guidelines - UnitedHealthcare Community Plan of Arizona
Last Modified 05.24.2019
Orfadin - Clinical Pharmacy Program Guidelines - UnitedHealthcare Community Plan of Arizona
Last Modified 07.17.2019
Orilissa.docx, Orilissa - Clinical Pharmacy Program Guidelines - UnitedHealthcare Community Plan of Arizona
Last Modified 03.31.2019
Orkambi - Clinical Pharmacy Program Guidelines - UnitedHealthcare Community Plan of Arizona
Last Modified 11.30.2018
Osphena - Clinical Pharmacy Program Guidelines - UnitedHealthcare Community Plan of Arizona
Last Modified 07.17.2019
Otezla- Clinical Pharmacy Program Guidelines - UnitedHealthcare Community Plan of Arizona
Last Modified 05.24.2019
Overactive Bladder (OAB) Agents - Clinical Pharmacy Program Guidelines - UnitedHealthcare Community Plan of Arizona
Last Modified 11.30.2018
Oxervate - Clinical Pharmacy Program Guidelines - UnitedHealthcare Community Plan of Arizona
Last Modified 04.24.2019
PAH Agents - Clinical Pharmacy Program Guidelines - UnitedHealthcare Community Plan of Arizona
Last Modified 07.19.2019
Palynziq - Clinical Pharmacy Program Guidelines - UnitedHealthcare Community Plan of Arizona
Last Modified 12.28.2018
Panretin - Clinical Pharmacy Program Guidelines - UnitedHealthcare Community Plan of Arizona
Last Modified 01.30.2019
Pediculicides - Clinical Pharmacy Program Guidelines - UnitedHealthcare Community Plan of Arizona
Last Modified 02.19.2019
Pomalyst (pomalidomide) - Clinical Pharmacy Program Guidelines - UnitedHealthcare Community Plan of Arizona
Last Modified 07.19.2019
Praluent - Clinical Pharmacy Program Guidelines - UnitedHealthcare Community Plan of Arizona
Last Modified 01.30.2019
Preferred Drugs - Clinical Pharmacy Program Guidelines - UnitedHealthcare Community Plan of Arizona
Last Modified 10.01.2018
Prevymis (letermovir) - Clinical Pharmacy Program Guidelines - UnitedHealthcare Community Plan of Arizona
Last Modified 08.30.2019

Prevymis (letermovir)
Procysbi (cysteamine bitartrate) - Clinical Pharmacy Program Guidelines - UnitedHealthcare Community Plan of Arizona
Last Modified 08.30.2019

Procysbi (cysteamine bitartrate)
Progesterone - Non-Oral - Clinical Pharmacy Program Guidelines - UnitedHealthcare Community Plan of Arizona
Last Modified 04.24.2019
Progesterone, Oral - Clinical Pharmacy Program Guidelines - UnitedHealthcare Community Plan of Arizona
Last Modified 07.17.2019
Promacta - Clinical Pharmacy Program Guidelines - UnitedHealthcare Community Plan of Arizona
Last Modified 03.31.2019
Proton Pump Inhibitors (PPI) - Clinical Pharmacy Program Guidelines - UnitedHealthcare Community Plan of Arizona
Last Modified 08.30.2019

Omeprazole capsule [Prilosec], Pantoprazole sodium tablet, Lansoprazole capsule [Prevacid], Esomeprazole magnesium OTC capsule [Nexium] 24 HR ‐ OTC], Esomeprazole magnesium granule [Nexium Granule Suspension], Lansoprazole solutab [Prevacid Solutab]
Provigil, Nuvigil.docx, Provigil / Nuvigil - Clinical Pharmacy Program Guidelines - UnitedHealthcare Community Plan of Arizona
Last Modified 03.31.2019
Pulmonary Arterial Hypertension (PAH) Agents - Clinical Pharmacy Program Guidelines - UnitedHealthcare Community Plan of Arizona
Last Modified 06.26.2018
Pulmozyme - Clinical Pharmacy Program Guidelines - UnitedHealthcare Community Plan of Arizona
Last Modified 04.24.2019
Quantity Limits - Clinical Pharmacy Program Guidelines - UnitedHealthcare Community Plan of Arizona
Last Modified 11.01.2018
Ranexa - Clinical Pharmacy Program Guidelines - UnitedHealthcare Community Plan of Arizona
Last Modified 11.01.2018
Ravicti - Clinical Pharmacy Program Guidelines - UnitedHealthcare Community Plan of Arizona
Last Modified 04.24.2019
Rectiv - Clinical Pharmacy Program Guidelines - UnitedHealthcare Community Plan of Arizona
Last Modified 12.28.2018
Regranex - Clinical Pharmacy Program Guidelines - UnitedHealthcare Community Plan of Arizona
Last Modified 12.28.2018
Relistor - Clinical Pharmacy Program Guidelines - UnitedHealthcare Community Plan of Arizona
Last Modified 01.30.2019
Renvela - Clinical Pharmacy Program Guidelines - UnitedHealthcare Community Plan of Arizona
Last Modified 09.28.2018
Repatha.docx, Repatha - Clinical Pharmacy Program Guidelines - UnitedHealthcare Community Plan of Arizona
Last Modified 03.31.2019
Revlimid - Clinical Pharmacy Program Guidelines - UnitedHealthcare Community Plan of Arizona
Last Modified 07.19.2019
Rhofade - Clinical Pharmacy Program Guidelines - UnitedHealthcare Community Plan of Arizona
Last Modified 11.01.2018
Rubraca - Clinical Pharmacy Program Guidelines - UnitedHealthcare Community Plan
Last Modified 11.30.2018
Ruconest - Clinical Pharmacy Program Guidelines - UnitedHealthcare Community Plan of Arizona
Last Modified 07.17.2019
Rydapt (midostaurin) - Clinical Pharmacy Program Guidelines - UnitedHealthcare Community Plan of Arizona
Last Modified 08.30.2019

Rydapt (midostaurin)
Samsca - Clinical Pharmacy Program Guidelines - UnitedHealthcare Community Plan of Arizona
Last Modified 11.30.2018
Sandostatin - Clinical Pharmacy Program Guidelines - UnitedHealthcare Community Plan of Arizona
Last Modified 11.30.2018
Sensipar - Clinical Pharmacy Program Guidelines - UnitedHealthcare Community Plan of Arizona
Last Modified 11.30.2018
Serevent Diskus - Clinical Pharmacy Program Guidelines - UnitedHealthcare Community Plan of Arizona
Last Modified 02.19.2019
SGLT-2 Inhibitors - Clinical Pharmacy Program Guidelines - UnitedHealthcare Community Plan of Arizona
Last Modified 07.19.2019
SGLT-2 Inhibitors - Clinical Pharmacy Program Guidelines - UnitedHealthcare Community Plan of Arizona
Last Modified 08.30.2019

Invokana (canagliflozin), Farxiga (dapagliflozin), Jardiance (empagliflozin), Invokamet (canagliflozin/metformin), Xigduo XR (dapagliflozin/metformin extended release), Synjardy (empagliflozin/metformin), Invokamet XR (canagliflozin/metformin extended release), Synjardy XR (empagliflozin/metformin extended release), Steglatro (ertugliflozin), Segluromet (ertugliflozin/metformin)
Short-Acting Opioid Products - Clinical Pharmacy Program Guidelines - UnitedHealthcare Community Plan of Arizona
Last Modified 08.15.2019

Short-Acting Opioids: Includes both brand and generic versions of the listed products unless otherwise noted: All salt forms, single and combination ingredient products, and all brand and generic formulations of the following: Butorphanol nasal spray, codeine, morphine, hydrocodone, hydromorphone, oxycodone, oxymorphone, pentazocine, tramadol, tapentadol, meperidine, levorphanol tartrate, dihydrocodeine, opium, benzhydrocodone Short-Acting Opioids – Cough and cold products: Includes both brand and generic versions of the listed products unless otherwise noted: Products containing codeine or hydrocodone in combinations with one or more of the following: homatropine, chlorpheniramine, guaifenesin, pyrilamine, brompheniramine, phenylephrine, triprolidine, dexchlorpheniramine, promethazine, pseudoephedrine.
Signifor - Clinical Pharmacy Program Guidelines - UnitedHealthcare Community Plan of Arizona
Last Modified 11.30.2018
Siliq- ARIZONA.docx, Siliq - Clinical Pharmacy Program Guidelines - UnitedHealthcare Community Plan of Arizona
Last Modified 03.31.2019
Simponi- Clinical Pharmacy Program Guidelines - UnitedHealthcare Community Plan of Arizona
Last Modified 05.24.2019
Sivextro - Clinical Pharmacy Program Guidelines - UnitedHealthcare Community Plan of Arizona
Last Modified 01.30.2019
Somavert - Clinical Pharmacy Program Guidelines - UnitedHealthcare Community Plan of Arizona
Last Modified 09.28.2018
Soritane - Clinical Pharmacy Program Guidelines - UnitedHealthcare Community Plan of Arizona
Last Modified 11.30.2018
Spinraza - Clinical Pharmacy Program Guidelines - UnitedHealthcare Community Plan of Arizona
Last Modified 07.17.2019
Spravato - Clinical Pharmacy Program Guidelines - UnitedHealthcare Community Plan of Arizona
Last Modified 07.19.2019
Sprycel - Clinical Pharmacy Program Guidelines - UnitedHealthcare Community Plan of Arizona
Last Modified 01.30.2019
Stelara - Clinical Pharmacy Program Guidelines - UnitedHealthcare Community Plan of Arizona
Last Modified 05.24.2019
Stivarga - Clinical Pharmacy Program Guidelines - UnitedHealthcare Community Plan of Arizona
Last Modified 08.30.2019

Stivarga (regorafenib)
Strensiq - Clinical Pharmacy Program Guidelines - UnitedHealthcare Community Plan of Arizona
Last Modified 07.19.2019
Sublingual Immunotherapy (SLIT) - Clinical Pharmacy Program Guidelines - UnitedHealthcare Community Plan of Arizona
Last Modified 05.24.2019
Suboxone / Subutex - Clinical Pharmacy Program Guidelines - UnitedHealthcare Community Plan of Arizona
Last Modified 07.19.2019
Sucraid - Clinical Pharmacy Program Guidelines - UnitedHealthcare Community Plan of Arizona
Last Modified 02.20.2019
Sutent - Clinical Pharmacy Program Guidelines - UnitedHealthcare Community Plan of Arizona
Last Modified 07.16.2019
Symdeko - Clinical Pharmacy Program Guidelines - UnitedHealthcare Community Plan of Arizona
Last Modified 05.24.2019
Symlin - Clinical Pharmacy Program Guidelines - UnitedHealthcare Community Plan of Arizona
Last Modified 07.19.2019
Synagis (Drug Policy) - Clinical Pharmacy Program Guidelines - UnitedHealthcare Community Plan of Arizona
Last Modified 12.21.2018
Synribo - Clinical Pharmacy Program Guidelines - UnitedHealthcare Community Plan of Arizona
Last Modified 11.01.2018
Tafinlar - Clinical Pharmacy Program Guidelines - UnitedHealthcare Community Plan of Arizona
Last Modified 05.24.2019
Tagrisso - Clinical Pharmacy Program Guidelines - UnitedHealthcare Community Plan of Arizona
Last Modified 01.30.2019
Takhzyro - Clinical Pharmacy Program Guidelines - UnitedHealthcare Community Plan of Arizona
Last Modified 01.30.2019
Taltz- ARIZONA.docx, Taltz - Clinical Pharmacy Program Guidelines - UnitedHealthcare Community Plan of Arizona
Last Modified 03.31.2019
Talzenna - Clinical Pharmacy Program Guidelines - UnitedHealthcare Community Plan of Arizona
Last Modified 07.17.2019
Tarceva - Clinical Pharmacy Program Guidelines - UnitedHealthcare Community Plan of Arizona
Last Modified 01.30.2019
Targretin - Clinical Pharmacy Program Guidelines - UnitedHealthcare Community Plan of Arizona
Last Modified 01.30.2019
Tavalisse - Clinical Pharmacy Program Guidelines - UnitedHealthcare Community Plan of Arizona
Last Modified 07.19.2019
Tegsedi.docx, Tegsedi - Clinical Pharmacy Program Guidelines - UnitedHealthcare Community Plan of Arizona
Last Modified 03.31.2019
Temodar - Clinical Pharmacy Program Guidelines - UnitedHealthcare Community Plan of Arizona
Last Modified 11.30.2018
Test Strips, Blood Glucose - Clinical Pharmacy Program Guidelines - UnitedHealthcare Community Plan of Arizona
Last Modified 07.19.2019
Thalomid (thalomide)- Clinical Pharmacy Program Guidelines - UnitedHealthcare Community Plan of Arizona
Last Modified 07.19.2019
Tibsovo - Clinical Pharmacy Program Guidelines - UnitedHealthcare Community Plan of Arizona
Last Modified 08.30.2019

Tibsovo (ivosidenib)
Tobramycin Inhalation - Clinical Pharmacy Program Guidelines - UnitedHealthcare Community Plan of Arizona
Last Modified 06.17.2019
Topical Androgens - Clinical Pharmacy Program Guidelines - UnitedHealthcare Community Plan of Arizona
Last Modified 11.01.2018
Topical NSAIDs - Clinical Pharmacy Program Guidelines - UnitedHealthcare Community Plan
Last Modified 08.31.2018
Topical NSAIDs.docx, Topical NSAIDs - Clinical Pharmacy Program Guidelines - UnitedHealthcare Community Plan of Arizona
Last Modified 03.31.2019
Topical Retinoid Products - Clinical Pharmacy Program Guidelines - UnitedHealthcare Community Plan of Arizona
Last Modified 02.25.2019
Trelegy Ellipta - Clinical Pharmacy Program Guidelines - UnitedHealthcare Community Plan of Arizona
Last Modified 08.30.2019

Trelegy Ellipta
Tremfya- ARIZONA.docx, Tremfya - Clinical Pharmacy Program Guidelines - UnitedHealthcare Community Plan of Arizona
Last Modified 03.31.2019
Tretinoin Capsules - Clinical Pharmacy Program Guidelines - UnitedHealthcare Community Plan of Arizona
Last Modified 02.20.2019
Triptans - Clinical Pharmacy Program Guidelines - UnitedHealthcare Community Plan of Arizona
Last Modified 07.19.2019
Tykerb - Clinical Pharmacy Program Guidelines - UnitedHealthcare Community Plan of Arizona
Last Modified 12.28.2018
Tymlos - Clinical Pharmacy Program Guidelines - UnitedHealthcare Community Plan of Arizona
Last Modified 01.30.2019
Uloric - Clinical Pharmacy Program Guidelines - UnitedHealthcare Community Plan of Arizona
Last Modified 09.28.2018
UnitedHealth Pharmaceutical Solutions, Tasigna - Clinical Pharmacy Program Guidelines - UnitedHealthcare Community Plan of Arizona
Last Modified 03.31.2019
Valchlor - Clinical Pharmacy Program Guidelines - UnitedHealthcare Community Plan of Arizona
Last Modified 11.30.2018
Vancocin - Clinical Pharmacy Program Guidelines - UnitedHealthcare Community Plan of Arizona
Last Modified 06.26.2018
Vancomycin - Clinical Pharmacy Program Guidelines - UnitedHealthcare Community Plan of Arizona
Last Modified 07.19.2019
Vecamyl - Clinical Pharmacy Program Guidelines - UnitedHealthcare Community Plan of Arizona
Last Modified 08.30.2019

Vecamyl (mecamylamine)
Vemlidy - Clinical Pharmacy Program Guidelines - UnitedHealthcare Community Plan of Arizona
Last Modified 12.28.2018
Venclexta - Clinical Pharmacy Program Guidelines - UnitedHealthcare Community Plan of Arizona
Last Modified 07.17.2019
Verzenio - Clinical Pharmacy Program Guidelines - UnitedHealthcare Community Plan of Arizona
Last Modified 07.19.2019
Vitrakvi.docx, Vitrakvi - Clinical Pharmacy Program Guidelines - UnitedHealthcare Community Plan of Arizona
Last Modified 03.31.2019
Vizimpro - Clinical Pharmacy Program Guidelines - UnitedHealthcare Community Plan of Arizona
Last Modified 01.30.2019
Votrient.docx, Votrient - Clinical Pharmacy Program Guidelines - UnitedHealthcare Community Plan of Arizona
Last Modified 03.31.2019
Vyndaqel and Vyndamax - Clinical Pharmacy Program Guidelines - UnitedHealthcare Community Plan of Arizona
Last Modified 08.30.2019

Vyndaqel (tafamidis meglumine), Vyndamax (tafamidis)
Xalkori - Clinical Pharmacy Program Guidelines - UnitedHealthcare Community Plan of Arizona
Last Modified 07.17.2019
Xeljanz / Xeljanz XR - Clinical Pharmacy Program Guidelines - UnitedHealthcare Community Plan of Arizona
Last Modified 11.01.2018
Xeljanz and Xeljanz XR - Clinical Pharmacy Program Guidelines - UnitedHealthcare Community Plan of Arizona
Last Modified 05.24.2019
Xenazine - Clinical Pharmacy Program Guidelines - UnitedHealthcare Community Plan of Arizona
Last Modified 12.28.2018
Xermelo - Clinical Pharmacy Program Guidelines - UnitedHealthcare Community Plan of Arizona
Last Modified 08.30.2019

Xermelo (telotristat ethyl)
Xifaxan - Clinical Pharmacy Program Guidelines - UnitedHealthcare Community Plan of Arizona
Last Modified 07.31.2018
Xolair - Clinical Pharmacy Program Guidelines - UnitedHealthcare Community Plan of Arizona
Last Modified 07.17.2019
Xopenex Respules - Clinical Pharmacy Program Guidelines - UnitedHealthcare Community Plan of Arizona
Last Modified 12.28.2018
Xospata - Clinical Pharmacy Program Guidelines - UnitedHealthcare Community Plan of Arizona
Last Modified 04.24.2019
Xtandi - Clinical Pharmacy Program Guidelines - UnitedHealthcare Community Plan of Arizona
Last Modified 12.28.2018
Xuriden - Clinical Pharmacy Program Guidelines - UnitedHealthcare Community Plan of Arizona
Last Modified 08.30.2019

Xuriden (uridine triacetate)
Xyrem - Clinical Pharmacy Program Guidelines - UnitedHealthcare Community Plan of Arizona
Last Modified 09.28.2018
Yonsa.docx, Yonsa - Clinical Pharmacy Program Guidelines - UnitedHealthcare Community Plan of Arizona
Last Modified 03.31.2019
Zejula - Clinical Pharmacy Program Guidelines - UnitedHealthcare Community Plan of Arizona
Last Modified 07.19.2019
Zelboraf - Clinical Pharmacy Program Guidelines - UnitedHealthcare Community Plan of Arizona
Last Modified 05.24.2019
Zetia - Clinical Pharmacy Program Guidelines - UnitedHealthcare Community Plan of Arizona
Last Modified 12.28.2018
Zolinza - Clinical Pharmacy Program Guidelines - UnitedHealthcare Community Plan of Arizona
Last Modified 01.30.2019
Zontivity - Clinical Pharmacy Program Guidelines - UnitedHealthcare Community Plan of Arizona
Last Modified 12.28.2018
Zortress - Clinical Pharmacy Program Guidelines - UnitedHealthcare Community Plan of Arizona
Last Modified 02.20.2019
Zydelig - Clinical Pharmacy Program Guidelines - UnitedHealthcare Community Plan of Arizona
Last Modified 11.30.2018
Zykadia - Clinical Pharmacy Program Guidelines - UnitedHealthcare Community Plan of Arizona
Last Modified 08.31.2018
Zytiga (abriaterone acetate) - Clinical Pharmacy Program Guidelines - UnitedHealthcare Community Plan of Arizona
Last Modified 07.17.2019
Zyvox - Clinical Pharmacy Program Guidelines - UnitedHealthcare Community Plan of Arizona
Last Modified 01.30.2019